News
EVFM
0.014
-0.71%
-0.000
Weekly Report: what happened at EVFM last week (0422-0426)?
Weekly Report · 2d ago
Weekly Report: what happened at EVFM last week (0415-0419)?
Weekly Report · 04/22 10:57
Weekly Report: what happened at EVFM last week (0408-0412)?
Weekly Report · 04/15 10:50
Weekly Report: what happened at EVFM last week (0401-0405)?
Weekly Report · 04/08 10:54
Weekly Report: what happened at EVFM last week (0325-0329)?
Weekly Report · 04/01 10:52
Evofem Biosciences Issues Update with Latest Presentation
TipRanks · 03/28 21:22
EVFM Stock Earnings: Evofem Biosciences Reported Results for Q4 2023
Evofem Biosciences reported earnings per share of -44 cents. The company reported revenue of $4.84 million. The stock was down 2.7% to $2.05 in the after-hours trading session on Tuesday.  
Investorplace · 03/27 17:52
*Evofem Biosciences 4Q Sales $4.8M >EVFM
Dow Jones · 03/27 12:37
*Evofem Biosciences 4Q Loss/Shr 44c >EVFM
Dow Jones · 03/27 12:36
Evofem Reports $18.2 million of Phexxi Net Product Sales in 2023
Evofem Biosciences, Inc. Announces financial results for the fourth quarter and year ended December 31, 2023. Third Consecutive Year of Phexxi Net Sales Growth. Total Operating Expense Reduced 64% from 2022 Levels. Entered into a definitive agreement to be acquired by Aditxt, Inc., in 2024.
PR Newswire · 03/27 12:36
Weekly Report: what happened at EVFM last week (0318-0322)?
Weekly Report · 03/25 10:54
Press Release: Evofem Negotiates Improved Rebate for Hormone-Free "In the Moment" Contraceptive PHEXXI with Medi-Cal
Evofem Negotiates Improved Rebate for Hormone-Free "In the Moment" Contraceptive PHEXXI with Medi-Cal. 7.4% improvement in Phexxi rebate to take effect July 1, 2024. PheXXi is the first and only locally-acting contraceptive gel approved by the FDA.
Dow Jones · 03/20 12:54
Weekly Report: what happened at EVFM last week (0311-0315)?
Weekly Report · 03/18 10:53
Weekly Report: what happened at EVFM last week (0304-0308)?
Weekly Report · 03/11 10:50
'France becomes first country to explicitly enshrine abortion rights in constitution' -Washington Post Report
Benzinga · 03/04 17:53
Weekly Report: what happened at EVFM last week (0226-0301)?
Weekly Report · 03/04 10:53
Weekly Report: what happened at EVFM last week (0219-0223)?
Weekly Report · 02/26 11:04
Weekly Report: what happened at EVFM last week (0212-0216)?
Weekly Report · 02/19 11:06
Weekly Report: what happened at EVFM last week (0205-0209)?
Weekly Report · 02/12 10:56
Weekly Report: what happened at EVFM last week (0129-0202)?
Weekly Report · 02/05 11:03
More
Webull provides a variety of real-time EVFM stock news. You can receive the latest news about Evofem Bioscienc through multiple platforms. This information may help you make smarter investment decisions.
About EVFM
Evofem Biosciences, Inc. is a commercial-stage biopharmaceutical company. It is engaged in developing and commercializing products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (STIs). Its product, Phexxi vaginal gel, is a hormone-free, woman-controlled, on-demand prescription contraceptive gel for women. Its lead clinical program is evaluating Phexxi (using the investigational name EVO100) for the prevention of chlamydia and gonorrhea in women. EVO200 vaginal gel (EVO200), its investigational candidate for the reduction of recurrent bacterial vaginosis (BV), uses the same vaginal potential of hydrogen (pH) modulator platform as Phexxi. It also focuses on developing Multipurpose Prevention Technology (MPT) vaginal gel for indications, including the prevention of human immunodeficiency virus (HIV) in women through Orion Biotechnology Canada Ltd.